Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ORKA Oruka Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $92.20 -3.9% | $16.00 -2.5% |
| StockIQ Score | 46D+ Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 44D | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 38F | 50C- |
| Fair Value | 50C- | 38F |
| News | 56C | 50C- |
| Quality | — | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Oruka Therapeutics (ORKA) outperforms Ascentage Pharma (AAPG) in investor confidence, fundamentals, and valuation, scoring 45, 46, and 50 respectively, compared to AAPG’s 37, 35, and 38. However, AAPG leads in growth with a score of 50 versus ORKA’s 38. ORKA’s overall rating is also stronger at "Moderate" versus AAPG’s "Weak." Technicals favor ORKA significantly, with 38 versus AAPG’s 18.
